Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson’s disease model in rats: Role of AMPK/SIRT-1/PGC-1α signaling and autophagy
-
Published:2024-09
Issue:
Volume:138
Page:112640
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Elesawy Wessam H.,
El-Sahar Ayman E.,
Sayed Rabab H.ORCID,
Ashour Ahmed M.ORCID,
Alsufyani Shuruq E.,
Arab Hany H.ORCID,
Kandil Esraa A.
Reference49 articles.
1. Challenges in the diagnosis of Parkinson’s disease;Tolosa;Lancet Neurol.,2021
2. Current and projected future economic burden of Parkinson’s disease in the U.S;Yang;NPJ Parkinsons Dis,2020
3. D. Aarsland, L. Batzu, G.M. Halliday, G.J. Geurtsen, C. Ballard, K. Ray Chaudhuri, D. Weintraub, Parkinson disease-associated cognitive impairment, Nature Reviews Disease Primers 2021 7:1 7 (2021) 1–21. 10.1038/s41572-021-00280-3.
4. A. Kouli, K.M. Torsney, W.-L. Kuan, Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis, Parkinson’s Disease: Pathogenesis and Clinical Aspects (2018) 3–26. 10.15586/CODONPUBLICATIONS.PARKINSONSDISEASE.2018.CH1.
5. Progress towards therapies for disease modification in Parkinson’s disease;Vijiaratnam;Lancet Neurol.,2021